Trial Profile
A Open label, Randomized, Multiple-dose, Drug-Drug interaction, non-fasting study Which Investigating pharmacokinetic of Abt-493 and Abt-530 with Sofosbuvir in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Glecaprevir (Primary) ; Pibrentasvir (Primary) ; Sofosbuvir
- Indications Hepatitis C
- Focus Pharmacokinetics
- 12 May 2016 New trial record